Abstract
HIV-1 Tat protein is released from HIV-1-infected cells and can enter non-permissive cells including neurons. Tat disrupts neuronal homeostasis and may contribute to the neuropathogenesis in people living with HIV (PLWH). The use of cocaine by PLWH exacerbates neuronal dysfunction. Here, we examined the mechanisms by which Tat and cocaine facilitate alterations in neuronal homeostatic processes. Bioinformatic interrogation of the results from RNA deep sequencing of rat hippocampal neurons exposed to Tat alone indicated the dysregulation of several genes involved in lipid and cholesterol metabolism. Following exposure to Tat and cocaine, the activation of cholesterol biosynthesis genes led to increased levels of free cholesterol and cholesteryl esters in rat neurons. Results from lipid metabolism arrays validated upregulation of several processes implicated in the biogenesis of β-amyloid and Alzheimer’s disease (AD), including sterol o-acyltransferase 1/acetyl-coenzyme A acyltransferase 1 (SOAT1/ACAT1), sortilin-related receptor L1 (SORL1) and low-density lipoprotein receptor-related protein 12 (LRP12). Further studies in Tat-treated primary neuronal cultures and brain tissues from HIV-1 transgenic mice as well as SIV-infected macaques confirmed elevated levels of SOAT1/ACAT 1 proteins. Our results offer novel insights into the molecular events involved in HIV and cocaine-mediated neuronal dysfunction that may also contribute to neuropathogenic events associated with the development of AD.
Similar content being viewed by others
Introduction
Antiretroviral therapy (ART) has significantly decreased the morbidity and mortality caused by HIV-1 infection, as well as progression toward AIDS1. Even though ART can efficiently block viral replication and restore CD4+ T-cell count, it has failed to eliminate the virus in all infected cells2. In turn, low levels of viral gene expression persist in people living with HIV (PLWH), even when plasma viral load is undetectable3. Thus, it is believed that some of the co-morbidities commonly observed in PLWH can be attributed to the presence of latent proviral DNA, called reservoirs, which express toxic viral proteins such as Tat that circulate and perturb homeostatic processes in surrounding cells and tissues4. In such cases, HIV-1 replication is inhibited by ART, while the proviral DNA integrated into the host genome continues to express low quantities of HIV proteins (e.g. Tat and Nef), subsequently leading to the emergence of diseases in the nervous, cardiovascular and endocrine systems, among others5,6. Furthermore, discontinuing ART can result in the reactivation of viral replication in most circumstances, suggesting a long-term risk for viral reactivation7,8.
HIV-associated neurologic dysfunction occurs in high rates among aging PLWH. These disorders are characterized by complications in the peripheral nervous system, as well as cognitive behavioral deficits across variety of domains including attention, learning and memory9,10,11,12. Gradual and persistent expression of the HIV-1 regulatory protein, Tat, has been recognized as a major cause in the emergence and development of neurocognitive disorders in PLWH taking ART. Although HIV-1 does not infect neurons, Tat released from infected cells in the brain, such as microglia, macrophage, and astrocytes, can enter into neurons and affects cellular functioning. Tat-induced neuronal injury and toxicity has been demonstrated in numerous in vitro and in vivo animal studies13,14. Tat has been shown to impair cell survival and communication pathways including bioenergetics15, calcium signaling16,17, apoptosis18 and neurotransmission19,20, however, the mechanisms by which Tat alters these processes to impair neuronal functioning remain poorly understood.
HIV-1-mediated changes in the transcriptome of HIV infected cells and tissues revealed widespread alterations in cellular pathways crucial for survival and functioning as well as processes that promote HIV-1 replication. Deep RNA sequencing of CD4+, CD8+ and CD14+ T-cells from PLWH demonstrated HIV-1-mediated changes in the transcriptome of these cells affecting metabolic, cell cycle and lipid profile pathways21,22. In addition, in HIV-1 infected macrophages, DNA and chromatin alterations have been reported23. Furthermore, earlier studies showed that treatment of peripheral blood lymphocytes from a healthy donor with HIV-1 Tat results in regulation of endogenous retroviruses including HEV-K24.
Transgenic rats harboring the HIV-1 genome served as a useful model to study the impact of HIV-1 on the central nervous system (CNS), and assessing neurobehavioral changes caused by the virus25,26,27. Using deep sequencing analysis of RNA transcripts, this model has been employed to identify altered patterns of gene expression in various regions of the brain28,29. Similarly, strategies were employed to evaluate impairments in expression of a variety of transcripts associated with working memory and cognition30. However, whether Tat alters the expression of specific processes impairing neuronal functioning that potentially contribute to molecular events associated with neurocognitive impairments, remains unknown.
The use of cocaine increases the risk for becoming infected by HIV and many studies have shown that together, HIV and cocaine exacerbate neurocognitive impairment31. Moreover, numerous in vitro and in vivo studies have reported that in combination, Tat and cocaine disrupt signaling cascades in the CNS and that these changes significantly affect functioning of uninfected bystander cells32,33,34. In fact, cocaine promotes viral replication in infected astrocytes15. Here, the interplay between Tat and cocaine in the context of disruption of neuronal homeostasis was addressed.
Lipid and cholesterol homeostasis are tightly controlled in brain in general and neurons in particular35,36. Impairment of this homeostasis has been widely linked to neurodegeneration and neurological disorders such as Alzheimer’s disease, Huntington’s disease and Parkinson’s disease, among others37,38,39. Through activation of Nitric Oxide (NO) synthesis, HIV has been associated with mitochondrial cholesterol accumulation in neurons40. HIV was also implied in the accumulation of cholesterol and ceramide in the infected individuals CNS as an indicator of HIV-associated neurocognitive disorders41. Antiretroviral therapy (ART) has been shown to increase HDL42 while reducing low density lipoprotein (LDL) cholesterol43. ART was also reported to improve cholesterol efflux capacity in individual infected with HIV44.
In this research, we utilized embryonic rat hippocampal neuron cultures to initially examine variations in the neuronal transcriptome following exposure to Tat and cocaine. Using a statistical clustering approach, a number of significantly dysregulated pathways were identified, most notable were those involved in lipid metabolism and cholesterol synthesis, as well as several other pathways involved in cytokine signaling and inflammatory responses, G-protein coupled receptors and olfactory receptors. A qRT-PCR lipid metabolism array revealed the upregulation of several genes that are implicated in the biogenesis of β-amyloid and Alzheimer’s disease (AD), including sterol o-acyltransferase 1/acetyl-coenzyme A acyltransferase 1 (SOAT1/ACAT1), sortilin-related receptor, L1 (SORL1) and low-density lipoprotein receptor-related protein 12 (LPR12). Results from analyses of HIV-1 transgenic mice (Tg26) cortical tissue and Tat-treated rat primary neuronal culture clearly demonstrated an increase in SOAT1/ACAT1 mRNA and protein levels. Furthermore, qRT-PCR array, western blotting and immunofluorescence imaging analyses validated these observations in Tat-treated rat neurons, Tg26 mice and SIV-infected macaque brain tissues. In a coordinated manner, the activation of cholesterol biosynthesis genes led to increased levels of free cholesterol and cholesteryl esters (CE) in rat neurons following exposure to Tat and cocaine. The current observations provide novel insights into the mechanisms involved in the manifestation of HIV-mediated neurocognitive disorders and suggest that similar pathological mechanisms may occur in the neuropathogenesis of AD.
Results
Global transcriptome analysis of hippocampal neurons in response to Tat and Cocaine
Primary cells derived from rat embryonic day 18 (E18) hippocampal tissue is highly enriched in neurons and has served as an in vitro model for studying many neuronal biological functions including formation of synaptic contacts and connectivity45. Here, we performed RNA-seq analysis of transcripts from rat hippocampal neurons after exposure to recombinant HIV-1 Tat protein and cocaine, either alone or in combination. The aligned RNA-seq data from neurons were transformed into the log2 of RPKM (Reads per Kilobase Million) unit and uni- and multivariate analysis were conducted (Fig. 1). The box plot of the distribution of log2 (RPKM) for control, cocaine, Tat and Tat/cocaine conditions shows mRNA levels at the minimum, maximum, median and first and third quantiles of the data (Fig. 1A). The checkpoints of distribution for the experimental conditions show no statistically significant differences. The similarity of the log2 (RPKM) distributions were also be captured by their probability density functions estimated using the Kernel method (Fig. S1).
Detailed multivariate analysis was performed by comparative study of the pairwise log2(RPKM)s and the results are presented by MA (log ratio vs. mean average) plots of cocaine vs. control, Tat vs. control, Tat/cocaine vs. cocaine and Tat/cocaine vs. Tat (Fig. 1B–E). A greater than two-fold downregulation compared to two-fold upregulation of genes was observed in different conditions (Fig. 1B,C). These results suggest that separately, Tat and cocaine induce lower transcription rates or decrease mRNA stability. On the other hand, Tat/cocaine co-treatment led to a higher ratio of upregulated transcripts when compared to Tat or cocaine alone (Fig. 1D,E).
Next, we performed the hierarchical clustering of the cellular mRNA and mitochondrial mRNA expression levels after log2(RPKM) transformation, respectively (Fig. 1F,G). We then compared the experimental conditions using hierarchical clustering complemented with heat-map visualization of the clustered gene groups and the co-expressed genes. This analysis provides a basis for the detection of clusters of genes that exhibit similar expression patterns under different conditions. As revealed by this analysis, cellular gene responses to Tat or cocaine are similar compared to control; whereas, Tat/cocaine co-treatment upregulates the expression of several specific families of genes (Fig. 1F and Table 1, gene names are not listed for presentation purposes). Moreover, mitochondrial gene responses to cocaine and Tat/cocaine conditions show higher correlations with one another suggesting that cocaine may be regulating mitochondrial gene expression profiles (Fig. 1G). In this context, the overall effects of Tat, cocaine, and Tat/cocaine were upregulation of mitochondrial gene expression, mostly affecting the tRNA family (Trny, Trne, Trnn, Trna, Trnq) that normally show low baseline expression levels. These effects may suggest changes to mitochondrial protein synthesis, but this requires further investigation. On the other hand, the highly expressed MT-COX and MT-ATP mRNAs remained unchanged across all treatments (Fig. 1G).
Functional annotations of highly modulated cellular pathways
The highly affected cellular processes in response to cocaine, Tat and Tat/cocaine combination are listed (Table 1). Notably, Tat and Tat/cocaine increased the mRNA of genes that express G-protein coupled receptors, a phenomenon which was absent in cocaine only treated neurons and control. Similarly, Tat and Tat/cocaine upregulated mRNAs for cytokine receptors including IL-3, IL-5 and IL-6, hence cellular response to cytokine stimulus (Fig. S2). Overall, Tat and Tat/cocaine upregulated the inflammatory pathways in neurons as represented by the cytokine activity and response to bacterial infections. This effect is mostly linked to the upregulation of TNF-α and interleukin family (Fig. S2). With cocaine alone, lower levels of mRNAs involved in the inflammation are observed, suggesting that Tat may be responsible for the upregulation. All three conditions promoted an increase in the rat chemical sense pathways including olfactory family genes. Hormone activity related mRNA levels were also increased in response to Tat and Tat/cocaine, while they were reduced by cocaine alone. Chemokine activity related mRNAs were downregulated by Tat and cocaine, while increased by Tat/cocaine co-treatments (Table 1). Overall, the results indicate a dominant effect of Tat on these pathways compared to cocaine, as Tat restores some of the cocaine inhibitory effects. In conclusion, Tat/cocaine promoted a stimulatory state compared to cocaine alone which showed inhibitory properties.
In addition, multiple regulatory pathways are modulated by Tat, cocaine and Tat/cocaine, compared to control. As indicated in Table S1, zinc ion binding-associated mRNAs are upregulated by Tat, cocaine and Tat/cocaine compared to the control. Thus, it is evident that Tat increases transcription and DNA-dependent pathways, and cocaine ameliorates this effect. Additionally, both cocaine and Tat led to significant increases in the RNA splicing and genes related to pre-mRNA 3′-splice binding sites. Also, cocaine upregulated spliceosome assembly related mRNAs. Cocaine, Tat and Tat/cocaine downregulated protein kinase signaling cascades (PKC in Tat and cocaine and PKA in Tat/cocaine), while cocaine increased mRNAs related to this pathway via the NFκB pathway (Table S1). We also observed that cocaine-induced upregulation of nerve growth factor receptor mRNA, while Tat caused induction of pathways related to CNS asymmetry in the neuronal development.
Differentially expressed gene (DEG)-based identification of neuronal pathways affected by Tat and Cocaine
Two distinct approaches were employed to identify highly altered genes by Tat and cocaine. For example, in the first approach, for each experimental condition, a list of DEGs that were up- or downregulated more than two-fold compared to the control were constructed. The lists were fed into BiNGO46, a Cytoscape application, for functional annotation of the overrepresented pathways. Both Tat (Fig. S3A) and cocaine (Fig. S3C) downregulated mRNAs in pathways related to the immune response and development/differentiation processes. Cocaine downregulated the expression of mRNAs associated with fatty acid metabolic pathways (Fig. S3C). Interestingly, both Tat and cocaine increased mRNAs related to pathways involved in stimulus detection (Fig. S3B,D). Treatment with cocaine increased mRNAs associated with lipid metabolism where lipid biosynthetic processes, steroid metabolic processes and cholesterol biosynthesis are highly overrepresented (Fig. S3D).
In the second approach, the k-means clustering method was utilized to generate a list of genes that highly and coordinately responded to the various experimental conditions. We selected 20 clusters based on the number of genes and their expression profiles (Fig. S4). In particular, we were interested in profiles that significantly responded to the Tat and cocaine treatments. Functional annotation of the groups of genes clustered in either a similar or a highly Tat/cocaine-responsive manner and led to the identification of additional overrepresented pathways. The sterol and more specifically, cholesterol metabolic pathways, lie at the center of the positively responding genes to both Tat and Tat/cocaine. Taken together, the RNA-Seq data along with the pathway analysis signifies the impact of Tat and Tat/cocaine on induction of lipid pathways.
Tat and cocaine significantly alter hippocampal neuronal lipid metabolism
To further verify altered gene expression patterns in neurons exposed to Tat, cocaine, or Tat/cocaine, a lipoprotein signaling and cholesterol metabolism qRT-PCR array consisting of genes involved in lipid metabolism was utilized. The qRT-PCR array assessed genes within five key pathways, including low density lipoprotein (LDL) and LDL receptors, high density lipoprotein (HDL), cholesterol transport, and cholesterol metabolism pathways. Results indicated the upregulation of 13 of the 84 genes measured (Table S2). Interestingly, the upregulated genes were primarily related to the cholesterol metabolism pathway (Fig. 2A). To further validate results from the qRT-PCR array, 3 of the 13 upregulated genes that showed more than 4-fold changes in expression, specifically LRP12 (an LDL receptor gene), SORL1 (important for amyloid precursor protein trafficking) and SOAT1/ACAT1 (important for synthesis of esterified cholesterol) and were assessed by qRT-PCR (Fig. 2C). qRT-PCR results confirmed the upregulation of these genes in primary rat cultures transfected with adenovirus mediated Tat (Ad-Tat) expression or exposed to recombinant Tat (rTat) (Fig. 2C,E). Given the pivotal role of the SOAT1/ACAT1 gene in cholesterol esterification as well as its important role in the progression of neurodegenerative diseases, such as AD and Parkinson’s disease, RNA and protein measurement validation experiments were focused on SOAT1/ACAT1. Our qRT-PCR analysis revealed a significant increase (p < 0.001) in SOAT1/ACAT1 in neurons exposed to Ad-Tat or rTat versus untreated control (Fig. 2D,E). Interestingly, in rat primary neurons, we did not observe any changes in SOAT1/ACAT1 expression levels when Ad-Tat/cocaine were applied together (Fig. 2D). To confirm that these changes occurred at protein levels as well, immunocytochemical analyses of rat primary hippocampal and cortical neurons showed Tat-mediated SOAT1/ACAT1 increase respectively (Fig. 3A,B). Increased protein levels of SOAT1/ACAT1 in cortical neurons was also confirmed via western blotting (Fig. 3C). An approximate increase of 25% in SOAT1/ACAT1 protein levels were observed after Tat exposure (p < 0.001) (Fig. 3D). Similarly, cortical tissue from Tg26 transgenic mice (Fig. 3E), as well as frontal cortex tissues from the SIV (Simian immunodeficiency virus) infected macaque revealed higher expression levels of SOAT1/ACAT1 (Fig. S5).
To confirm that higher expression of SOAT1/ACAT1 was observed in the brains of HIV patients, we inquired if changes in mRNA in brain tissues from age-matched HIV- controls, HIV + ART naïve and HIV + ART-treated brains were reported using the raw microarray data publicly available on the NCBI GEO (Fig. S6A). These results indicated that significantly (p = 0.0003) higher mRNA levels of SOAT1/ACAT1 were present in HIV + ART naïve brains compared to age-matched controls or HIV + ART + samples. However, cocaine did not directly alter the SOAT1/ACAT1 mRNA expression levels in the rat neurons (Figs 2D and S6D).
Effect of Tat and cocaine treatment on the neuronal cholesteryl esters and free cholesterol
Intercellular cholesterol levels were measured in rat primary neurons exposed to recombinant Tat, cocaine and Tat/cocaine. Cocaine, Tat and Tat/cocaine increased levels of free cholesterol, total cholesterol and cholesteryl esters (CE), respectively (Fig. 4A–C). The levels of increase in free cholesterol and total cholesterol are less than 50%; however, in cocaine, Tat and Tat/cocaine treated neurons, CE were increased 4, 3- and 9-fold, respectively (Fig. 4C). These results correlate with the activating effect of Tat and cocaine on the gene expression of cholesterol biosynthesis pathways (Fig. 7S).
Discussion
We investigated HIV-1 Tat-, cocaine- and Tat/cocaine-mediated changes in the neuronal transcriptome through applying RNA next generation sequencing. Our findings revealed significant changes in multiple neuronal pathways important for neuronal survival and proper functioning. The results showed dysregulation in the lipid pathway in neurons, which overlaps with functional signaling changes reported in AD45. Previous studies have investigated changes in the global transcriptome of HIV-1 infected T-cells, B-cells, macrophages and the whole brain. In these studies, functional annotation of DEGs revealed HIV-1 adversely affects the TCA cycle, TGF-β signaling, reductive carboxylate cycle, cytokine-cytokine receptor interaction, cell cycle, DNA repair, apoptosis, immune response pathways and JAK-STAT signaling in PBMCs, CD4+ T cells and monocytes22,47. RNA-sequencing of HIV-1 infected monocytes and gene ontology analyses uncovered some of the HIV-1 infection specific effects on gene expression and chromatin remodeling23. Others have shown changes in apoptosis, cell cycle, lipid metabolism, proteasome function, protein trafficking, transcriptional regulation pathways, toll-like receptor signaling, cytokine–cytokine receptor interactions and cell cycle regulation48,49. Moreover, HIV-1 infection altered distinct signature pathways in the brains of HIV-transgenic rats including B-cell translocation gene (BTG) family-mediated cell cycle regulation and toll-like receptor signaling in the prefrontal cortex, and JAK/STAT signaling and eukaryotic initiation factor 2 signaling in the hippocampus and striatum, respectively29.
SOAT1/ACAT1 is an enzyme localized in the endoplasmic reticulum that synthesizes CE from free cholesterol and fatty acids and has an essential role in the aggregation of β-amyloid in the CNS. SOAT1/ACAT1 overexpression results in the production of excessive amounts of hydrophobic cholesteryl esters, which in turn, may lead to β-Amyloid (Aβ) deposition from the cleaved amyloid precursor protein (APP)50. In an animal study, SOAT1/ACAT1 KO mice on a high fat diet (HFD) showed improved cognitive functioning, higher insulin tolerance, less pro-inflammatory cytokines (including TNF-α and IL-6) and attenuated overexpression and phosphorylation of GFAP caused by HFD compared to wild type51. It has also been shown that SOAT1/ACAT1 KO or inhibition increases phagocytic uptake of Aβ-42 by microglia and enhances lysosomal autophagy in an mTOR-independent manner52,53. In mouse hippocampal neurons, SOAT1/ACAT1 ablation resulted in increased 24(S)-hydroxycholesterol synthesis rate and consequently rapid declines of hAPP and HMGR proteins54, suggesting the regulatory effect of SOAT1/ACAT1 protein on the cholesterol biosynthesis upstream proteins.
Cholesterol turn-over is tightly regulated in neurons where the majority of cholesterol exists as free cholesterol with CE constituting about 1% of the total cholesterol under normal conditions. Our RNA-seq data suggest the activation of mevalonate pathway under the Tat treatment. This activation is followed by upregulation of DHCR7 (which is essential to convert dehydrocholesterol to cholesterol) and upregulated cholesterol biosynthesis. This increase in the cholesterol level is reflected in our total cholesterol assay in the neurons undergoing Tat and Tat/cocaine treatment by about 40%. Changes in neuronal cholesterol levels also indicated that both free cholesterol and CE contribute to the elevation of total cholesterol. Tat-mediated cholesterol upregulation may indicate neuronal attempts to repair the cellular membrane or synaptic loss caused by Tat uptake55. Our RNA-Seq and qRT-PCR array also suggest Tat-induced upregulation of sterol regulatory element‐binding proteins (SREBPs) mRNAs required for regulation of the lipid and cholesterol biosynthesis genes (data not shown) as well as Lipoprotein receptor-related protein (Lrp1) gene. Lrps are of key importance in the transport of lipids and signaling. Also Lrp1 has been recognized as the main gateway of HIV-1 Tat endocytosis in neurons56. On the other hand, this upregulation may reflect the Tat-specific function to recruit the cholesterol metabolism pathway and provide the cholesterol required for capsid formation as well as virus replication, even though HIV does not infect neurons. Viral replication-mediated formation of CEs is implicated by some studies. For example, in vitro infection of hepatitis C virus has been linked to the upregulation of ACAT1 and ACAT2 genes and elevated CE synthesis, hypothesized to be a main component in lipoviral particles57. Our findings correlate with previous studies showing the accumulation of cholesterol in monocytes infected with HIV58 and HIV-induced foam cell formation through upregulation of TNF-α59. TNF-α upregulation is known to positively regulator SOAT1/ACAT1 expression60. Our observations demonstrate the upregulation of SOAT1/ACAT1 at the mRNA level in Tat-treated rat neurons, Tg26 mice and SIV-infected macaque brains. Our analysis of the microarray data published on the NCBI Geo platform61 confirms the SOAT1/ACAT1 mRNA overexpression of both ART-naïve and ART-treated HIV+ patients. Furthermore, our immunoassays show upregulation of SOAT1/ACAT1 protein in Tg26 transgenic mice and SIV macaques. Moreover, SOAT1/ACAT1 upregulation corresponds to the CE increase in neuronal cultures exposed to cocaine (>4 fold), Tat protein (>3 fold) and Tat/cocaine (>9 fold). Multiple reports have linked the Aβ plaque formation and deposition with elevation in CE54,62. Our observations also suggest Tat-mediated accumulation of Aβ in neurons (Fig. S6B,C). Our qRT-PCR data showing the upregulation of SORL1 (a member of LDLR family) and LRP12 may reflect an adaptive neuronal response to the accumulation of Aβ induced by increased CE formation. Therefore, Tat-mediated upregulation of cholesterol biosynthesis in neurons and subsequent induction of CE production may support a novel mechanism describing the amyloid fibril deposition repeatedly reported in HIV infection63.
Dysregulation of lipid metabolic pathway by HIV-1, as it relates to sphingolipid and ceramide, has been extensively investigated and the outcome suggested that overproduction of ceramide could eventually lead to neuronal cell injury and death41,64,65,66. Interestingly, the role of sphingolipid metabolism in the neuropathogenesis of AD via ApoE4 was also demonstrated, suggesting the importance of lipid metabolism in neurodegenerative diseases ranging from HIV-1 dementia to AD67,68. Here, we identified another pathway that provides a new insight to HIV-1 neuropathogenesis and age-related changes observed in HIV-associated neurocognitive disorders (HAND). Figure 5 provides a schematic of the model proposed by this research. HIV-1 Tat and cocaine promote the upregulation of cholesterol biosynthesis genes, subsequently leading to the elevated amount of free cholesterol. Further upregulation of the SOAT1/ACAT1 gene and protein results in the formation of excess CEs and amyloid-plaques which eventually contribute to the Tat/cocaine-mediated neuronal injury.
Materials and Methods
Ethics Statement
Guidelines regarding the care and use of laboratory animals were applied during all stages of the experimental procedures. The Temple University Institutional Animal Care and Use Committee approved all experimental protocols. In one series of experiments we used HIV-1 transgenic mice, Tg26, as described previously69,70.
HIV transgenic mice - Tg26
The HIV Tg26 transgenic is a well-described mouse model which is hemizygous, encoding the entire pNL4–3 HIV-1 genome with deletion of a segment of gag/pol genes and expresses viral proteins such as Tat and Nef 71. The Tg26 mice pathology is similar to HIV-associated symptoms72.
Macaque model
Indian rhesus macaques (Macaca mulatta) were inoculated intravenously with SIVmac251 viral swarm (5 ng p27; Tulane National Primate Research Center’s [(TNPRC; Covington, LA) Viral Core] and subsequently CD8-depleted through administration of 10 mg/kg of anti-CD8 antibody subcutaneously at 6 days post-infection (dpi) and 5 mg/kg of antibody intravenously at 8 and 12 dpi (Nonhuman Primate Reagent Resource)59. The SIV+ animals were sacrificed according to humane endpoints consistent with the recommendations of the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals. The development of simian AIDS was determined post-mortem by the presence of Pneumocystis carinii-associated interstitial pneumonia, Mycobacterium avium-associated granulomatous enteritis, hepatitis, lymphadenitis, and/or adenovirus infection of surface enterocytes in both small and large intestines. For ART treatments, animals were not only SIV-infected and CD8 depleted, but also received a triple ART regimen of Raltegravir (22 mg/kg oral twice daily, Merck), Tenofovir (30 mg/kg subcutaneous once daily, Gilead), and Emtricitabine (10 mg/kg subcutaneous once daily, Gilead) at 21 dpi until the timed sacrificed at 118–120 dpi. Animals were anesthetized with ketamine–HCL and euthanized by intravenous pentobarbital overdose. Animals used in the study were housed at the TNPRC. All animals used in this study were handled in strict accordance with American Association for Accreditation of Laboratory Animal Care with the approval of the Institutional Animal Care and Use Committee of Tulane University.
Rat embryonic cell culture and treatments
Embryonic day 18 (E18) rat hippocampal neurons were obtained from the Comprehensive NeuroAIDS Center (CNAC) and prepared and maintained as described previously20. After 10 days in culture, neurons were treated with 50 ng/ml recombinant HIV-1 Tat protein or adenovirus (MOI: 1) expressing Tat as well as 2 µM cocaine in sodium citrate (pH 5.0), which was repeated every 24 hours for a total of 72 hours20. Neurons were exposed to rTat (101, Immunodiagnostics Inc, MA, 50 ng/ml), Cocaine hydrochloride (2 μM, Sigma-Aldrich, St. Louis, MO) and rTat/cocaine for 48 hours. Negative controls received no treatments or were transduced with adeno-null (Ad-null). Following the treatments, total RNA was prepared using Trizol (ThermoFisher, Carlsbad, CA) according to the manufacturer’s protocol. RNA quality was determined on an agarose gel. Neurons were harvested after 72 hours for RNA isolation and qRT-PCR validations. RNA-Seq analysis was performed at Applied Biological Materials Inc. (British Colombia, Canada) and with 80 million 2 × 75 bp paired-end reads.
RNA isolation and cDNA preparation
Total RNA was isolated using the Direct-zol RNA prep mini kit (Zymo Research, CA, USA) following the manufacturer’s protocol. cDNA synthesis on total RNA samples was performed with High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific) according to manufacturer’s protocol.
PCR Arrays
The amplified cDNA was added to the RT2 qRT-PCR SYBR green Master Mix (QIAGEN) following the array protocol. Real-Time PCR was performed on the LightCycler® 96 (Roche) and used SYBR green detection with the following thermal profile: segment 1–1 cycle: 95 °C for 10 minutes, segment 2–40 cycles: 95 °C for 15 seconds followed by 60 °C for 1 minute. All data from PCR was collected by the LightCycler® 96 Instrument Software (Version 2.0, May 2013, Software Version 1.1). To validate the result of targeted genes, primers were designed considering the exons junction positions in the genomic DNA, primer specificity and efficiencies checked by RT-PCR using Q5 High-Fidelity PCR Kit (City, State, New England Biolabs). All qRT-PCR reactions were performed with the LightCycler® 96 and Roche cyber green qRT-PCR Master Mix buffer according to manufacturer’s protocol. Relative quantification was performed via Actin primer reference gene normalization. Primer sequences are shown below (Table 2).
Analysis of real-time PCR array data
Each array contained six separate housekeeping genes (Actb, B2m, Hprt1, Ldha, Rplp1, RGDC) that were used for normalization of the sample data. Ct data were entered into the QIAGEN PCR array Data Analysis Web Portal to perform quantification and calculate fold changes using the ΔΔ Ct method73. Any Ct value >35 was considered to be negative. If the Ct value of the genomic DNA control was >30, then no genomic DNA was detectable.
Isolation of protein and Western blot analysis
Neurons were washed with PBS and lysed in RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% NP40, 1:100 protease inhibitor cocktail, Calbiochem, San Diego, CA). Cell debris and insoluble particles were removed by centrifugation and protein concentration was determined by the Bradford method (BioWorld, Columbus, OH). Equal amounts of proteins were separated on SDS-PAGE and transferred to Odyssey nitrocellulose membrane (Li-Cor, Lincoln, NE) by wet transfer (Bio-Rad, Philadelphia, PA). The following primary antibodies were used for Western blotting: anti-SOAT1/ACAT1 (1:1,000, Proteintech, Rosemont, IL), anti-GAPDH (1:2,000, Santa Cruz, sc-32233).
Immunolabeling and microscopy
Primary neurons in two-well chamber slides were washed with PBS and fixed in 4% Paraformaldehyde for 15 min. Neurons were then washed three times with PBS and permeabilized with 0.1% triton X100 in PBS for 5 min, followed by washing three times with PBS. Neurons were blocked at room temperature for 1 hour in blocking buffer (10% FBS, 0.1% triton X100 in PBS). Neurons were subsequently incubated with primary antibodies in blocking buffer at 4 °C overnight. Detection of labeled proteins was conducted via Alexa Flour (1:1,000, ThermoFisher Scientific) in blocking buffer for 1 hour at room temperature. After mounting slides with VECTASHIELD hard set mounting medium with DAPI (Vector Laboratories, Burlingame, CA), images were captured using a Leica microscope system. Formalin fixed paraffin embedded brain tissues from mouse (30 days old) and SIV- control and SIV+ macaques sectioned at 5um following standard protocol. Briefly, after dewaxing, sections were placed in boiling water plus 1% antigen unmasking solution. Mouse sections were probed with anti-SOAT1/ACAT1 (1:200) and anti- β3-tubulin (1:500). Macaque sections were probed with anti-SOAT1/ACAT1 (1:200) and β3-tubulin (1:500). The fluorescent labeling followed the same procedure as described for immunocytochemistry.
Free and total cholesterol and cholesteryl ester quantification
E18 rat primary neurons were cultured in 12-well plates (106/well) and were maintained 12 DIV (days in vitro) prior to the treatments. Recombinant Tat protein and cocaine (dissolved in sodium citrate buffer, pH = 5.5) were added at final concentrations of 50 ng/ml and 4 μM, respectively. This treatment was repeated every 24 hours for a total of 72 hours (15 DIV) following which cells were harvested using chloroform/isopropanol/NP-40 buffer. After solvent removal, the extracted lipid droplets under the control, cocaine, Tat and Tat\cocaine were used to determine the free and total cholesterol and CE according to manufacturer’s instructions using the cholesterol quantification kit (Sigma-Aldrich, St. Louis, MO).
RNA-Seq data acquisition and alignment
Short-reads were obtained through an Illumina® next generation sequencing facility (Novogene, Chula Vista, CA), with each library including 80 million single-end reads of 75 bp length. Short-reads were aligned versus the reference genome of rat (Rattus Norvegicus Rnor_6.0.85) with the corresponding annotation file in the gtf format, both obtained from NCBI. The alignment utilized Bowtie algorithm with the following parameters: maq error of 70, seed length of 28 and maximum backtracks of 800. The computational capacity was provided by a dual-Xeon CPU computer benefitting from CUDA parallel computing platform implemented using NVIDIA® Tesla M2090 and Quadro FX 580.
Probe definition and expression profile analysis
After aligning the short-reads, the resulting BAM files were exported into the SeqMonk® environment, where the relative abundance of reads was computed for the defined probes (genes). The probes were defined according to the gtf annotation file. For the probe generation step, we considered the feature probe generator and designed the probe sets for the mRNAs. Each probe represented the gene’s exons where exact duplicates were removed. For the quantification step, the read count quantification scheme was adopted. The reads were counted on the opposite strand of the probe and the total read count were corrected per millions of reads and the reads only were counted within the probes. After counting the number of reads, this number was normalized to the probe length (in base pairs). For the visualization and analysis purposes, log2 of the computed normalized read counts was calculated.
Hierarchical clustering
Hierarchical clustering was performed using the mRNA read count data. The outcome of this analysis was the presence of different clusters under control, Tat, cocaine and Tat/cocaine. The groups (clusters) were represented using a dendrogram, where the members of each cluster are of higher similarity with each other than the members of other clusters. This analysis provides information on how the expression profile of a certain gene is compared to the rest of the genes and whether there are similarly expressed genes which may lead to the conclusions of the relationships of the genes within each cluster.
MA plot generation
To capture the expression variations in each pair, \({M}_{X,Y}={\mathrm{log}}_{2}{{\rm{RPKM}}}_{Y}-{\mathrm{log}}_{2}{{\rm{RPKM}}}_{X}\) and \({A}_{X,Y}=\frac{1}{2}({\mathrm{log}}_{2}{{\rm{RPKM}}}_{Y}+{\mathrm{log}}_{2}{{\rm{RPKM}}}_{X})\) were calculated and plotted versus each other, where X and Y denote two experimental conditions. This approach allows the application a fold change threshold, for example 2, which can identify the ratio of the genes that show 2 fold up- or down-regulation.
Correlation network analysis
The Spearman’s rank correlation was used to derive the correlation between the expression profiles of genes of interest with respect to each other. This analysis provided a framework to identify genes showing the most similar response to the input conditions, helping to determine the groups of inter-related genes for the validation step. In this analysis, we used this measure to derive a group of genes that show the highest (absolute value of 0.995) with our target genes at the mRNA expression level.
Functional annotation and gene ontology
To further examine the impact of Tat- and cocaine-mediated changes in the neuronal transcriptome and detect impairments in the neuronal pathways, the expression profiles of the whole transcriptome were supplied to the pathway analysis algorithms in the AltAnalyze®74. environment. The algorithms were supplied with multiple databases such as KEGG and WikiPathways to obtain the most updated versions of the metabolic and regulatory pathways. As an output, the software package generated a list of regulatory pathways based on the gene’s annotations which were most significantly impacted by the experimental conditions. Gene ontology (GO)-based functional annotation and pathway analysis of overrepresented genes and visualization were performed using the Cystoscope applications of Bingo and EnrichmentMap75. Two types of approaches were essentially employed to determine the input genes fed into the applications: i) based on the expression fold change and ii) based on being recognized within the same expression pattern clusters. This step was followed by detailed pathway analysis to investigate the GO-detected overrepresented pathways in PathVisio76 environment.
Statistical analysis
The MathWorks MATLAB® was used to post-process the normalized read count data. The statistical toolbox was utilized to perform different tasks including clustering, correlation network analysis and visualization. t-test has been used in all our studies to compute p-values. Quantified data show mean ± StDev. The significance levels were considered as following: *p < 0.01, **p < 0.005, ***p < 0.001.
References
UNAIDS. Global AIDS Monitoring 2018 - Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS, http://www.unaids.org/en/resources/documents/2018/Global-AIDS-Monitoring (2018).
Lewden, C. et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. JAIDS Journal of Acquired Immune Deficiency Syndromes 46, 72–77 (2007).
Kulpa, D. A. & Chomont, N. HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide? Journal of virus eradication 1, 59 (2015).
Cary, D. C. & Peterlin, B. M. Targeting the latent reservoir to achieve functional HIV cure. F1000Research 5 (2016).
Eugenin, E. A. et al. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. The American journal of pathology 172, 1100–1111 (2008).
Hearps, A. C., Martin, G. E., Rajasuriar, R. & Crowe, S. M. Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing. Current HIV/AIDS Reports 11, 20–34 (2014).
Van Lint, C., Bouchat, S. & Marcello, A. HIV-1 transcription and latency: an update. Retrovirology 10, 67 (2013).
Hill, A. L. et al. Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV. PLoS pathogens 12, e1005535 (2016).
Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988 (2001).
McArthur, J. C. HIV dementia: an evolving disease. Journal of neuroimmunology 157, 3–10 (2004).
Carey, A. N., Sypek, E. I., Singh, H. D., Kaufman, M. J. & McLaughlin, J. P. Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behavioural brain research 229, 48–56 (2012).
Ances, B. M. & Ellis, R. J. In Seminars in neurology. 086-092 (Copyright© 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.).
King, J., Eugenin, E., Buckner, C. & Berman, J. HIV tat and neurotoxicity. Microbes and infection 8, 1347–1357 (2006).
Nath, A. & Steiner, J. Synaptodendritic injury with HIV-Tat protein: what is the therapeutic target? Experimental neurology 251, 112 (2014).
Norman, J. P. et al. HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One 3, e3731 (2008).
Tahrir, F. G. et al. Dysregulation of Mitochondrial Bioenergetics and Quality Control by HIV‐1 Tat in Cardiomyocytes. Journal of cellular physiology (2018).
Lapierre, J., Rodriguez, M., Ojha, C. R. & El-Hage, N. Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse. Journal of Neuroimmune Pharmacology, 1–16 (2018).
Jacotot, E. et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Journal of Experimental Medicine 191, 33–46 (2000).
Fitting, S. et al. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biological psychiatry 73, 443–453 (2013).
Ahooyi, T. M., Shekarabi, M., Decoppet, E. A., Langford, T. D. & Khalili, K. Network Analysis of Hippocampal Neurons by Microelectrode Array in the Presence of HIV‐1 Tat and Cocaine. Journal of cellular physiology (2017).
Rotger, M. et al. Genome-wide mRNA expression correlates of viral control in CD4 + T-cells from HIV-1-infected individuals. PLoS pathogens 6, e1000781 (2010).
Olvera-García, G. et al. A transcriptome-based model of central memory CD4 T cell death in HIV infection. BMC genomics 17, 956 (2016).
Deshiere, A. et al. Global mapping of the macrophage-HIV-1 transcriptome reveals that productive infection induces remodeling of host cell DNA and chromatin. Scientific reports 7, 5238 (2017).
Gonzalez-Hernandez, M. J. et al. Regulation of the HERV-K (HML-2) transcriptome by the HIV-1 Tat protein. Journal of virology, JVI. 00556–00514 (2014).
McLaurin, K. A., Booze, R. M. & Mactutus, C. F. Progression of temporal processing deficits in the HIV-1 transgenic rat. Scientific reports 6, 32831 (2016).
McLaurin, K. A., Booze, R. M. & Mactutus, C. F. Selective developmental alterations in the HIV-1 transgenic rat: opportunities for diagnosis of pediatric HIV-1. Journal of neurovirology 23, 87–98 (2017).
McLaurin, K. A., Li, H., Booze, R. M., Fairchild, A. J. & Mactutus, C. F. Unraveling individual differences in the HIV-1 transgenic rat: Therapeutic efficacy of methylphenidate. Scientific reports 8, 136 (2018).
Repunte-Canonigo, V. et al. Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Molecular neurodegeneration 9, 26 (2014).
Li, M. D. et al. Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One 8, e59582 (2013).
Levine, A. J. et al. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer’s disease. BMC medical genomics 6, 4 (2013).
Buch, S. et al. Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. Journal of Neuroimmune Pharmacology 6, 503 (2011).
Javadi-Paydar, M., Roscoe, R. F. Jr., Denton, A. R., Mactutus, C. F. & Booze, R. M. HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum. PloS one 12, e0188404 (2017).
Natarajaseenivasan, K. et al. Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity. Cell death & disease 9, 415 (2018).
Cotto, B. et al. Cocaine and HIV‐1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV‐associated neurocognitive disorders in cocaine user patients. Glia 66, 889–902 (2018).
Ko, M. et al. Cholesterol-mediated neurite outgrowth is differently regulated between cortical and hippocampal neurons. Journal of Biological Chemistry (2005).
Pooler, A. M., Xi, S. C. & Wurtman, R. J. The 3‐hydroxy‐3‐methylglutaryl co‐enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons. Journal of neurochemistry 97, 716–723 (2006).
Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T. & Shoulson, I. Altered cholesterol and fatty acid metabolism in Huntington disease. Journal of clinical lipidology 4, 17–23 (2010).
Wang, Q. et al. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Experimental neurology 230, 27–34 (2011).
Di Paolo, G. & Kim, T.-W. Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nature Reviews Neuroscience 12, 284 (2011).
Perumal, M. B. & Dhanasekaran, S. HIV associated dementia: role for neurosteroids. Medical hypotheses 78, 672–674 (2012).
Bandaru, V. V. R. et al. A lipid storage–like disorder contributes to cognitive decline in HIV-infected subjects. Neurology 81, 1492–1499 (2013).
Meynard, J.-L. et al. Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir. Journal of the International Association of Physicians in AIDS Care 7, 311–316 (2008).
Wohl, D. A. et al. Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy. Clinical infectious diseases 47, 1105–1108 (2008).
Ocampo, A. et al. Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. Journal of Antimicrobial Chemotherapy (2018).
Grabrucker, A., Vaida, B., Bockmann, J. & Boeckers, T. M. Synaptogenesis of hippocampal neurons in primary cell culture. Cell and tissue research 338, 333 (2009).
Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448–3449 (2005).
Massanella, M. et al. Differential gene expression in HIV-infected individuals following ART. Antiviral research 100, 420–428 (2013).
Van den Bergh, R. et al. Transcriptome analysis of monocyte-HIV interactions. Retrovirology 7, 53 (2010).
Wu, J. Q. et al. Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology 435, 308–319 (2013).
Bhattacharyya, R. & Kovacs, D. M. ACAT inhibition and amyloid beta reduction. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1801, 960–965 (2010).
Xu, N. et al. Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet. Biochemical and biophysical research communications 499, 105–111 (2018).
Shibuya, Y., Chang, C. C., Huang, L.-H., Bryleva, E. Y. & Chang, T.-Y. Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1–42 clearance. Journal of Neuroscience 34, 14484–14501 (2014).
Shibuya, Y. et al. Acyl-coenzyme A: cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer’s disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiology of aging 36, 2248–2259 (2015).
Bryleva, E. Y. et al. ACAT1 gene ablation increases 24 (S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proceedings of the National Academy of Sciences 107, 3081–3086 (2010).
Mishra, A., Gordon, V. D., Yang, L., Coridan, R. & Wong, G. C. H. I. V. TAT Forms Pores in Membranes by Inducing Saddle‐Splay Curvature: Potential Role of Bidentate Hydrogen Bonding. Angewandte Chemie International Edition 47, 2986–2989 (2008).
Liu, Y. et al. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nature medicine 6, 1380 (2000).
Read, S. A., Tay, E., Shahidi, M., George, J. & Douglas, M. W. Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production. Journal of General Virology 95, 1900–1910 (2014).
Feeney, E. R. et al. The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation. The Journal of infectious diseases 207, 628–637 (2012).
Maisa, A. et al. Monocytes from HIV+ individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. AIDS (London, England) 29, 1445 (2015).
Lei, L. et al. TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation. Journal of lipid research 50, 1057–1067 (2009).
Borjabad, A. et al. Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS pathogens 7, e1002213 (2011).
Murphy, S. R. et al. Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer’s disease. Molecular Therapy 21, 1497–1506 (2013).
Green, D. A. et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids 19, 407–411 (2005).
Haughey, N. J. et al. Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 55, 257–267 (2004).
Bandaru, V. V. et al. Associative and predictive biomarkers of dementia in HIV-1–infected patients. Neurology 68, 1481–1487 (2007).
Cutler, R. et al. Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63, 626–630 (2004).
Bandaru, V. V. R. et al. ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer’s but not normal brain. Neurobiology of aging 30, 591–599 (2009).
Haughey, N. J., Bandaru, V. V., Bae, M. & Mattson, M. P. Roles for dysfunctional sphingolipid metabolism in Alzheimer’s disease neuropathogenesis. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1801, 878–886 (2010).
Kearns, A. C. et al. Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model. Journal of neurovirology, 1–12 (2018).
Dickie, P. et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185, 109–119 (1991).
Kopp, J. B. et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1genes. Proceedings of the National Academy of Sciences 89, 1577–1581 (1992).
Curreli, S. et al. B cell lymphoma in HIV transgenic mice. Retrovirology 10, 92 (2013).
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods 25, 402–408 (2001).
Emig, D. et al. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic acids research 38, W755-W762 (2010).
Merico, D. et al. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PloS one 5, e13984 (2010).
van Iersel, M. P. et al. Presenting and exploring biological pathways with PathVisio. BMC bioinformatics 9, 399 (2008).
Acknowledgements
The authors wish to thank past and present members of the Department of Neuroscience and Center for Neurovirology for their sharing of reagents and ideas. We thank Michael Duggan for his comments on the manuscript. We also thank C. Papaleo for editorial assistance. This work was made possible by grants awarded by the NIH (P30MH092177, P01DA037830, R01DA42706, R01DA013137) to KK.
Author information
Authors and Affiliations
Contributions
Designed experiments: K.K., T.M.A., B.T., M.S., Performed experiments: T.M.A., M.S., B.T., Analyzed data: K.K., T.M.A., B.T., Interpreted data: T.M.A., K.K., J.G., B.T., T.B., T.D.L., S.A., P.K.D., Prepared manuscript: T.M.A., K.K., B.T., T.B., T.D.L., J.G., S.A.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mohseni Ahooyi, T., Shekarabi, M., Torkzaban, B. et al. Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing. Sci Rep 8, 16300 (2018). https://doi.org/10.1038/s41598-018-34539-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-34539-9
Keywords
This article is cited by
-
HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status
GeroScience (2021)
-
The lncRNA LOC102549805 (U1) modulates neurotoxicity of HIV-1 Tat protein
Cell Death & Disease (2020)
-
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation
Journal of Neuroimmune Pharmacology (2020)
-
Perturbation of synapsins homeostasis through HIV-1 Tat-mediated suppression of BAG3 in primary neuronal cells
Cell Death & Disease (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.